Literature DB >> 691920

Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin.

E W Kreutzer, F D Milligan.   

Abstract

Pseudomembranous colitis (PMC) is an infrequent but serious complication of oral and intravenous antibiotic therapy. Twelve patients with antibiotic-associated PMC, documented by sigmoidoscopy and rectal biopsy, were treated with cholestyramine resin. The mean time from the institution of therapy to cessation of diarrhea was 2.1 days. The response interval bore no relationship to the time symptoms were present prior to therapy. Complete resolution of sigmoidoscopic and histologic evidence of PMC usually accompanied or followed cessation of diarrhea. Obstipation was reported in 5 of 12 patients as a side effect of cholestyramine treatment. Therapy should be continued for up to five days after cessation of diarrhea to prevent recurrence of active PMC. Cholestyramine resin is shown to be an effective treatment for antibiotic-associated PMC.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 691920

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  19 in total

Review 1.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 2.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

3.  The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.

Authors:  R E Ariano; G G Zhanel; G K Harding
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

Review 4.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

Review 5.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  Treatment of Recurrent Clostridium difficile Diarrhea.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

7.  Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.

Authors:  B A Walters; R Roberts; R Stafford; E Seneviratne
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

8.  Rapid detection of Clostridium difficile toxin in human feces.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

9.  Antimicrobial agent-associated colitis and diarrhea.

Authors:  W L George
Journal:  West J Med       Date:  1980-08

10.  Bacitracin therapy in antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.